Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

6th Annual Neoantigen Based Therapies US Summit 2021 | October 26 - 28, 2021 | Digital Event

6th Annual Neoantigen Based Therapies US Summit 2021 | October 26 - 28, 2021 | Digital Event


Date of beginning

Tuesday, 26 October 2021


3 days




Rochelle Allen


This email address is being protected from spambots. You need JavaScript enabled to view it.


Buoyed by the successes of vaccine platforms in the covid setting, the neoantigen field is re-energized and back with a bang, with a plethora of neoantigen therapeutic candidates heading to the clinic or progressing through to the next phase of trials. With the neoantigen community now doubling down on its efforts focusing on cell-based approaches and realizing the potential of a new and novel class of shared neoantigens, the 6th Neoantigen Based Therapies US Summit will return to your screens this October 26-28 to bring you an abundance of new data, innovative insights and valuable lessons learned on how to drive meaningful clinical responses. This is your best chance in 2021 to accelerate the selection, identification, and validation of personalized and shared neoantigens to create meaningful T cell responses. As the only summit focused on the exploding field of Neoantigen based Therapies, and committed to bringing you the hottest content there is to offer, you can look forward to engaging with the likes of: - Mathias Vormehr, Director Cancer Vaccines, BioNTech SE- Stephen Schoenberger, Professor, La Jolla Institute for Immunology- Karin Joss, Head of R and D, Gristone Bio- Andres Gutierrez, Executive Vice President, CMO, Advaxis Inc- Joann Peters, VP Clinical and Business Operations, Geneos Therapeutics- Julia Kodysh, Senior Scientist, Computational Research, Icahn School of Medicine, Mount Sinai- Christopher Gallen, Chairman and CEO, Treos Bio Ltd- Albrecht Meichle, VP Regulatory Affairs and CMC, Vaximm- Paul Higham, CEO, Valo Therapeutics- And many more... This forum will provide you with exclusive data and critical insights from the movers and shakers of the neoantigen field, covering the full end to end landscape of supercharging development of supercharge vaccine and cell immunotherapies for solid tumors and beyond. We hope you can join us at the largest gathering of the neoantigen community this October! URLs:Tickets: Prices:Conference + Bootcamp Day: USD 2897.0,Conference + Workshop Day: USD 2897.0,Conference Only: USD 2099.0 Date and Time: On Tuesday October 26, 2021 at 9:30 am (ends Thursday October 28, 2021 at 5:30 pm)